YU39102A - Postupak dobijanja statina iz fermentacione smeše - Google Patents
Postupak dobijanja statina iz fermentacione smešeInfo
- Publication number
- YU39102A YU39102A YU39102A YUP39102A YU39102A YU 39102 A YU39102 A YU 39102A YU 39102 A YU39102 A YU 39102A YU P39102 A YUP39102 A YU P39102A YU 39102 A YU39102 A YU 39102A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- compound
- recovering
- fermentation broth
- statin compounds
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/33—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with hydroxy compounds having more than three hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
- C07C2602/28—Hydrogenated naphthalenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nanotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Manufacturing & Machinery (AREA)
- Cardiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Opisan je novi postupak za dobijanje jedinjenja iz fermentacione smeše, koji uključuje faze nastajanja obogaćenog rastvora jedinjenja ekstrakcijom, dobijanje soli jedinjenja iz obogaćenog rastvora, prečišćavanje soli jedinjenja i prevođenje tako dobijene soli jedinjenja u odgovarajuću metalnu so jedinjenja.[A novel process for recovering a compound from a fermentation broth that includes the stages of forming an enriched solution of the compound by extraction, obtaining a salt of the compound from the enriched solution, purifying a salt of the compound and trans-salifying the salt of the compound to a metal salt of the compound is disclosed.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16805699P | 1999-11-30 | 1999-11-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU39102A true YU39102A (sh) | 2006-01-16 |
Family
ID=22609918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU39102A YU39102A (sh) | 1999-11-30 | 2000-11-28 | Postupak dobijanja statina iz fermentacione smeše |
Country Status (22)
Country | Link |
---|---|
US (3) | US6444452B1 (sh) |
EP (1) | EP1265604B1 (sh) |
JP (5) | JP3881240B2 (sh) |
KR (1) | KR20030026920A (sh) |
CN (2) | CN1754872A (sh) |
AT (2) | ATE342717T1 (sh) |
AU (1) | AU1804601A (sh) |
CA (1) | CA2393057C (sh) |
CY (1) | CY1105925T1 (sh) |
DE (3) | DE04010770T1 (sh) |
DK (1) | DK1265604T3 (sh) |
ES (2) | ES2273737T3 (sh) |
HR (1) | HRP20020454A2 (sh) |
HU (1) | HUP0204012A3 (sh) |
MX (1) | MXPA02005283A (sh) |
PL (1) | PL364918A1 (sh) |
PT (1) | PT1265604E (sh) |
RU (1) | RU2002114072A (sh) |
SK (1) | SK7342002A3 (sh) |
WO (1) | WO2001039768A1 (sh) |
YU (1) | YU39102A (sh) |
ZA (1) | ZA200203912B (sh) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7141602B2 (en) * | 1998-09-18 | 2006-11-28 | Lek Pharmaceuticals D.D. | Process for obtaining HMG-CoA reductase inhibitors of high purity |
US6682913B1 (en) * | 1999-02-03 | 2004-01-27 | Institute For Drug Research Ltd. | Microbial process for preparing pravastatin |
EP1265604B1 (en) * | 1999-11-30 | 2006-10-18 | TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság | Process for recovering statin compounds from a fermentation broth |
JP2003516959A (ja) * | 1999-12-14 | 2003-05-20 | ビオガル ジョジセルジャール アール テー. | プラバスタチンナトリウムの新規フォーム |
US20050215636A1 (en) * | 2000-10-05 | 2005-09-29 | Vilmos Keri | Pravastatin sodium substantially free of pravastatin lactone and EPI-pravastatin, and compositions containing same |
IL155194A0 (en) * | 2000-10-05 | 2003-11-23 | Biogal Pharmaceutical Co Ltd | Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same |
JP2002121172A (ja) * | 2000-10-16 | 2002-04-23 | Sankyo Co Ltd | プラバスタチン又はその薬理上許容される塩の精製方法 |
DE10119718A1 (de) * | 2001-04-21 | 2002-10-31 | Boehringer Ingelheim Pharma | Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff |
JP2003026634A (ja) * | 2001-07-17 | 2003-01-29 | Mercian Corp | プラバスタチンナトリウム塩の製造方法 |
US6716615B2 (en) | 2002-02-27 | 2004-04-06 | Yung Shin Pharmaceutical Ind. Co., Ltd. | Strains of saccharaothrix, process for producing pravastatin using the strains and isolation process of (HMG)-CoA reductase |
KR100540761B1 (ko) * | 2002-08-09 | 2006-01-16 | 코바이오텍 (주) | 프라바스타틴 나트륨의 제조방법 |
EP1477471A1 (en) * | 2003-05-14 | 2004-11-17 | Chunghwa Chemical Synthesis & Biotech Co., Ltd. | Process for purifying pravastin sodium from a fermentation broth |
PT1641447E (pt) * | 2003-11-24 | 2008-12-10 | Teva Gyogyszergyar Zartkoeruee | Método de purificação da pravastatina |
SI1697383T1 (sl) * | 2003-12-05 | 2014-09-30 | Biocon Limited | Postopek za čiščenje takrolimusa |
WO2006046130A2 (en) * | 2004-10-29 | 2006-05-04 | Ranbaxy Laboratories Limited | Process for the preparation of pravastatin |
WO2006086680A1 (en) * | 2005-02-09 | 2006-08-17 | Teva Gyógyszergyár Zártköruen Muködo Részvénytársaság | Methods of making pravastatin sodium |
JP4813841B2 (ja) * | 2005-07-25 | 2011-11-09 | キユーピー株式会社 | プラバスタチンナトリウムの製造方法 |
DE102006028817A1 (de) * | 2006-06-21 | 2007-12-27 | Evonik Degussa Gmbh | Aufarbeitung von Reaktionslösungen aus Ganzzell-Biotransformationen |
WO2009078033A2 (en) * | 2007-12-18 | 2009-06-25 | Themis Medicare Limited | Isolation and recovery of simvastatin in lactone form or in the form of an acid salt from the harvested fermentation broth |
CN102046582B (zh) * | 2008-04-02 | 2013-09-18 | 中化帝斯曼制药有限公司荷兰公司 | 普伐他汀萃取 |
IN2009MU00380A (sh) * | 2009-02-18 | 2010-04-02 | ||
CN102993145B (zh) * | 2011-09-19 | 2015-06-03 | 北大方正集团有限公司 | 一种提取纯化洛伐他汀的方法 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4319039A (en) * | 1979-06-15 | 1982-03-09 | Merck & Co., Inc. | Preparation of ammonium salt of hypocholesteremic fermentation product |
DK149080C (da) * | 1980-06-06 | 1986-07-28 | Sankyo Co | Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre |
ATE69602T1 (de) * | 1985-09-13 | 1991-12-15 | Sankyo Co | Hydroxy-ml-236b-derivate, deren herstellung und anwendung. |
US4857547A (en) * | 1988-01-07 | 1989-08-15 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
US4857522A (en) * | 1988-03-21 | 1989-08-15 | E. R. Squibb & Sons, Inc. | Derivatives of pravastatin for inhibiting cholesterol biosynthesis |
US5180589A (en) * | 1988-03-31 | 1993-01-19 | E. R. Squibb & Sons, Inc. | Pravastatin pharmaceuatical compositions having good stability |
US5099035A (en) * | 1989-02-27 | 1992-03-24 | E. R. Squibb & Sons, Inc. | Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same |
US5140012A (en) * | 1990-05-31 | 1992-08-18 | E. R. Squibb & Sons, Inc. | Method for preventing onset of restenosis after angioplasty employing pravastatin |
US5202029A (en) * | 1991-03-13 | 1993-04-13 | Caron Kabushiki Kaisha | Process for purification of hmg-coa reductase inhibitors |
US5157025A (en) * | 1991-04-01 | 1992-10-20 | E. R. Squibb & Sons, Inc. | Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug |
NZ250609A (en) * | 1992-12-28 | 1995-07-26 | Sankyo Co | Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments |
SI9300303A (en) | 1993-06-08 | 1994-12-31 | Krka Tovarna Zdravil | Process for isolation of hypolipemic effective substance |
US5616595A (en) | 1995-06-07 | 1997-04-01 | Abbott Laboratories | Process for recovering water insoluble compounds from a fermentation broth |
US5942423A (en) | 1995-06-07 | 1999-08-24 | Massachusetts Institute Of Technology | Conversion of compactin to pravastatin by actinomadura |
US5883109A (en) * | 1996-07-24 | 1999-03-16 | Bristol-Myers Squibb Company | Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug |
WO1998037220A1 (en) * | 1997-02-20 | 1998-08-27 | Dsm N.V. | Nitrogen feed in statin fermentation |
AU9264598A (en) * | 1997-08-22 | 1999-03-16 | Gist-Brocades B.V. | Statin production by fermentation |
SI9800046A (sl) * | 1998-02-18 | 1999-08-31 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze visoke čistosti |
SI20072A (sl) * | 1998-09-18 | 2000-04-30 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze |
PL350317A1 (en) * | 1999-02-03 | 2002-12-02 | Inst Drug Res Ltd | Microbial process for preparing pravastatin |
US6682913B1 (en) * | 1999-02-03 | 2004-01-27 | Institute For Drug Research Ltd. | Microbial process for preparing pravastatin |
HUP9902352A1 (hu) | 1999-07-12 | 2000-09-28 | Gyógyszerkutató Intézet Kft. | Eljárás pravasztatin mikrobiológiai előállítására |
EP1265604B1 (en) * | 1999-11-30 | 2006-10-18 | TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság | Process for recovering statin compounds from a fermentation broth |
IL155194A0 (en) * | 2000-10-05 | 2003-11-23 | Biogal Pharmaceutical Co Ltd | Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same |
-
2000
- 2000-11-28 EP EP00980834A patent/EP1265604B1/en not_active Expired - Lifetime
- 2000-11-28 AU AU18046/01A patent/AU1804601A/en not_active Abandoned
- 2000-11-28 CN CNA2005100739122A patent/CN1754872A/zh active Pending
- 2000-11-28 DK DK00980834T patent/DK1265604T3/da active
- 2000-11-28 DE DE04010770T patent/DE04010770T1/de active Pending
- 2000-11-28 AT AT00980834T patent/ATE342717T1/de not_active IP Right Cessation
- 2000-11-28 YU YU39102A patent/YU39102A/sh unknown
- 2000-11-28 KR KR1020027006920A patent/KR20030026920A/ko not_active IP Right Cessation
- 2000-11-28 MX MXPA02005283A patent/MXPA02005283A/es unknown
- 2000-11-28 PL PL00364918A patent/PL364918A1/xx unknown
- 2000-11-28 CA CA002393057A patent/CA2393057C/en not_active Expired - Fee Related
- 2000-11-28 DE DE60037687T patent/DE60037687D1/de not_active Expired - Lifetime
- 2000-11-28 SK SK734-2002A patent/SK7342002A3/sk unknown
- 2000-11-28 JP JP2001541501A patent/JP3881240B2/ja not_active Expired - Fee Related
- 2000-11-28 RU RU2002114072/13A patent/RU2002114072A/ru not_active Application Discontinuation
- 2000-11-28 DE DE60031447T patent/DE60031447T2/de not_active Expired - Fee Related
- 2000-11-28 CN CN00818725A patent/CN1433305A/zh active Pending
- 2000-11-28 AT AT04010770T patent/ATE382344T1/de not_active IP Right Cessation
- 2000-11-28 PT PT00980834T patent/PT1265604E/pt unknown
- 2000-11-28 ES ES00980834T patent/ES2273737T3/es not_active Expired - Lifetime
- 2000-11-28 WO PCT/US2000/032391 patent/WO2001039768A1/en active IP Right Grant
- 2000-11-28 US US09/723,711 patent/US6444452B1/en not_active Expired - Fee Related
- 2000-11-28 ES ES04010770T patent/ES2239937T1/es active Pending
- 2000-11-28 HU HU0204012A patent/HUP0204012A3/hu unknown
-
2002
- 2002-05-16 ZA ZA200203912A patent/ZA200203912B/en unknown
- 2002-05-23 HR HR20020454A patent/HRP20020454A2/xx not_active Application Discontinuation
- 2002-07-23 US US10/200,149 patent/US6689590B2/en not_active Expired - Fee Related
-
2003
- 2003-11-05 US US10/700,567 patent/US20040115781A1/en not_active Abandoned
-
2004
- 2004-07-13 JP JP2004206262A patent/JP2004350687A/ja active Pending
-
2005
- 2005-10-19 JP JP2005304900A patent/JP2006055174A/ja not_active Withdrawn
-
2006
- 2006-05-22 JP JP2006141646A patent/JP2006273861A/ja active Pending
-
2007
- 2007-01-15 CY CY20071100052T patent/CY1105925T1/el unknown
-
2008
- 2008-02-06 JP JP2008026632A patent/JP4343987B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU39102A (sh) | Postupak dobijanja statina iz fermentacione smeše | |
YU63602A (sh) | Postupak za prečišćavanje fermentacionog bujona | |
AP1668A (en) | Method for separating hemicelluloses from a biomass containing hemicelluloses and biomass and hemicelluloses obtained by said method. | |
CA2018692A1 (fr) | Procede de preparation de l'acide ascorbique | |
HU9601857D0 (en) | New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them | |
MEP2208A (xx) | Postupak za pripremanje citaloprama | |
GB9720969D0 (en) | Process | |
NZ534232A (en) | Process for the manufacture of hmg-coa reductase inhibitors | |
PL332511A1 (en) | Method of hydroxyalkylating phenols | |
WO2005047276A3 (de) | Verfahren zur herstellung von statinen | |
PL342511A1 (en) | Process for obtaining simvastatin and its derivatives | |
CA1245226A (en) | METHOD FOR THE PREPARATION OF HMG-COA REDUCTASE INHIBITORS AND INTERMEDIATE COMPOUNDS | |
SI0977883T1 (en) | Improved process for the fermentative production of penicillin | |
IL146811A0 (en) | Novel method for preparing benzoperhydroisoindole compounds | |
BG103858A (en) | Method for heavy metals elimination | |
AU7652100A (en) | Method for extracting bacterio-rhodopsin | |
HUP9903478A2 (hu) | Új eljárás klavulánsav sójának előállítására | |
AU2542400A (en) | Method for producing l-ascorbic acid | |
HUP9904328A2 (hu) | 3-(Hidroxi-metil)-cefalosporin oldószeres extrakciója | |
Keri et al. | Method of purifying statins from a fermentation broth | |
MXPA02008693A (es) | Procedimiento para producir simvastatina. | |
BG103737A (en) | Method for the preparation of derivatives of 4h-4-oxo-quinolysine-3-carboxylic acid | |
MXPA04004537A (es) | Derivados de gabusectina, metodo para produccion de los mismos y uso de los mismos. | |
TW327173B (en) | Process for producing methanediphosphonate compound | |
AU5681100A (en) | Method for producing 4,6-dichloropyrimidine |